Originally presented February 13, 2019 as part of the UNC Cancer Network RN and Allied Health Lecture Series. This Self-Paced, Online Course expired March 12, 2020.
This is a Non-Credit course and does NOT offer continuing education credits.
Presenter
Jacob Hill, ND, MS
Postdoctoral Research Fellow, Program on Integrative Medicine
Department of Physical Medicine & Rehabilitation
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill
Safety Considerations When Managing Dietary Supplements in Cancer Care
Jacob Hill’s main area of focus is integrative medicine and oncology. This lecture will cover various safety considerations regarding the combination of dietary supplements (herbal medicines, nutraceuticals, vitamins, minerals, etc.) and conventional cancer treatment. The lecture will discuss herb/drug interactions, mechanism interactions, food/drug interactions, as well as health systems and health behavior considerations. This lecture is intended to assist oncology providers in discussing dietary supplements with their patients and supporting the safe management of dietary supplements in cancer care.
Learning Outcomes
- Define herb/drug interactions and identify potential safety concerns when using herbal medicines with cancer care.
- Describe and provide an example of a mechanism of interaction between a dietary supplement and cancer treatment medication.
- Discuss health systems and health behavior considerations that increase the risk of a safety concern regarding dietary supplements in cancer care.
Credits Offered
- 1.0 ANCC (CNE) hours of study
- 1.0 ACPE CE Credit
- 1 ASRT Category A CE Credit
- General Participation
Requirements
To receive credit for this course, you must:
- Watch a lecture video recording.
- Complete the lecture post test and obtain a passing score of 80% or higher.
- Complete the course evaluation.
- Select credit type.
Estimated course completion time: 1 hour
Disclosures
This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. Thomas Shea consults for Spectrum Pharma and receives research support from Millennium, Otsuka, GSK, BMS, Novartis and Seattle Genetics. Dr. James Coghill, MD, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.
The presenter, Jacob Hill, ND, MS, has no conflicts of interest relevant to this presentation.
Accreditation
This is a Non-Credit course and does NOT offer continuing education credits.
Disclaimer
Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.